abrdn Focused U.S. Small Cap Active ETF Q2 2025 Commentary

The Fund gained but underperformed the Russell 2000 Index, driven by sector-specific performance with healthcare and materials lagging, while consumer discretionary and financials excelled, influenced by individual company earnings, guidance shifts, and tariff impacts. The broader market environment was characterized by persistent tariff uncertainty, easing geopolitical tensions, and a Federal Reserve maintaining rates despite investor anticipation of future cuts. Amidst this volatility, the Fund strategically adjusted its portfolio, initiating new positions in areas like specialty insurance and healthcare REITs, while divesting from companies facing growth or tariff-related headwinds. Despite the macroeconomic uncertainty, the Fund remains optimistic on long-term small-cap opportunities, emphasizing quality businesses and secular tailwinds.

Analysis

The fund, while delivering a positive gross return, underperformed its Russell 2000 benchmark, primarily due to weakness in its healthcare and materials sector holdings. Stock-specific issues were significant detractors; Corcept Therapeutics (CORT) fell on a sales miss attributed to distribution issues, Graphic Packaging (GPK) declined on soft volumes and cost inflation, and Merit Medical Systems (MMSI) lowered its guidance citing tariff pressures. Conversely, outperformance was driven by the consumer discretionary and financials sectors, with individual contributors like REV Group (REVG) raising its annual guidance and Donnelley Financial Solutions (DFIN) benefiting from an expected rise in capital markets activity. This performance occurred within a volatile macroeconomic environment characterized by uncertainty surrounding US tariff policies and persistent inflation, which prompted the Federal Reserve to hold its target rate at 4.25%–4.50%. Despite market expectations for two 25 bps rate cuts, the Fed's commentary suggests a more cautious outlook. In response to these conditions, the fund manager has actively repositioned the portfolio, divesting from companies with deteriorating outlooks like Terreno Realty (TRNO) due to tariff uncertainty, and initiating positions in firms with perceived secular advantages, such as American Healthcare REIT (AHR) and Skyward Specialty Insurance (SKWD).

Key Decisions for Investors

• Investors should closely monitor individual company guidance and fundamentals, as stock-specific execution is creating significant performance divergence even amidst broad macroeconomic themes like tariffs.
• Given the fund's strategic pivot and the market's reaction, consider overweighting high-quality small-caps with resilient business models and secular growth drivers, such as those in niche insurance or healthcare REITs, which may be less correlated with geopolitical trade disputes.
• The disconnect between market expectations for 50 bps in rate cuts and the Federal Reserve's more hawkish stance presents a key risk; therefore, maintain a cautious stance on rate-sensitive assets and prepare for potential volatility around future inflation data and FOMC announcements.
• Evaluate portfolio exposure to sectors directly impacted by trade policy and input costs, such as materials and select industrial segments, as exemplified by the negative performance of GPK and MMSI.